Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DULOXETINE HYDROCHLORIDE USP, with a corresponding US DMF Number 21478.
Remarkably, this DMF maintains an Active status since its submission on March 29, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 23, 2018, and payment made on February 09, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II